Atlas Trials

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

Clinical trial NCT00117598 · COMPLETED

Trial details

NCT number
NCT00117598
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lymphoma
Start date
2005-05-01
Primary completion
2007-08-01
Enrollment
169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.